Camlin Fine Sciences opened higher at ₹89.90, compared with its previous close of ₹89.44. During today's session, the stock has traded between ₹88.60 and ₹91.40, with an average traded price of ₹89.75. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Camlin Fine Sciences is now worth
₹ 4,825.00
resulting in a loss of
₹ 5,175.00 (51.75%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+1.34 (+1.50%)
Day High
₹91.40
Day Low
₹88.60
Day Open
₹89.90
Prev Close
₹89.44
Volume
4,87,194
Value Traded
₹4.37 Cr
1W Return
-0.42%
1M Return
-10.72%
3M Return
-29.37%
6M Return
-13.27%
1Y Return
-54.52%
Market Cap (₹ Cr.)
1,744
PE Ratio
2,977.70
PB Ratio
1.65
Dividend Yield
-
ROE
-3.15%
ROCE
3.03%
Book Value (₹)
54.01
Face Value (₹)
1.00
EPS (TTM)
-1.65
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-0.42%
6 Week
-
1 Month
-10.72%
3 Month
-29.37%
9 Month
-39.96%
Camlin Fine Sciences seeks shareholder approval for Atul Pradhan as director
Camlin Fine Sciences seeks approval to appoint Atul Pradhan as independent director. Five-year term begins September 11, 2026, pending shareholder vote. E-voting window runs from September 17 to October 16, 2026. Pradhan brings consulting experience from KPMG and Transfolign Consulting.
28 days agoCamlin Fine Sciences Q1FY27 loss widens to ₹336m on FX hits
Camlin Fine Sciences reported a Q1FY27 consolidated net loss of ₹336.22 million, driven by FX losses and an exceptional insurance claim shortfall, despite a 27.5% YoY revenue surge to ₹5,198.79 million. Gross debt decreased to ₹6,400 million, but working capital pressures may necessitate additional credit lines of up to ₹2,000 million.
1mo agoCamlin Fine Sciences shareholders approve FY26 financials, reappoint directors
Camlin Fine Sciences Limited concluded its 33rd AGM on August 11, 2026, where shareholders approved the FY26 audited financial statements and reappointed two non-executive directors. The meeting saw high participation, with promoters voting unanimously in favor and public institutions polling over 84% of their holdings. All resolutions passed with over 99.99% support.
2mo agoCamlin Fine Sciences Q1 Results: Earnings call scheduled for Aug 11, 2026
Camlin Fine Sciences Limited has announced a Q1 FY27 earnings conference call on August 11, 2026 at 5:00 PM IST to discuss unaudited financial results for the quarter ended June 30, 2026. The call will be led by Chairman & Managing Director Mr. Ashish Dandekar, Managing Director Mr. Nirmal Momaya, and CFO Mr. Santosh Parab. Dial-in access has been provided for participants across India, the USA, UK, Singapore, and Hong Kong. The intimation was filed by Company Secretary Rahul Sawale on August 4, 2026, in compliance with SEBI LODR Regulation 30.
2mo agoCamlin Fine Sciences promoter releases pledge on 4,000 shares
Promoter Ashish Subhash Dandekar releases pledge on 4,000 shares of Camlin Fine Sciences on July 24, 2026. The move follows repayment of borrowings by the company. Encumbered holdings drop to 1,49,50,000 shares (7.78%).
2mo agoCamlin Fine Sciences schedules 33rd AGM for August 11
Camlin Fine Sciences Limited will conduct its 33rd Annual General Meeting on August 11, 2026, via video conferencing. Shareholders as of August 5, 2026, are eligible to vote, with remote e-voting open from August 8 to August 10. The Annual Report for FY 2025-26 is available electronically.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,497.60 | +1.35% | ₹1,52,437.66 | 56.20 | -0.86% | |
| ₹2,492.00 | +0.14% | ₹73,869.07 | 33.91 | -17.61% | |
| ₹4,550.80 | -1.16% | ₹49,990.54 | 84.18 | +22.07% | |
| ₹8,468.00 | -1.09% | ₹43,434.38 | 55.68 | +78.61% | |
| ₹660.00 | -0.21% | ₹33,301.90 | 41.50 | +44.90% | |
| ₹1,715.70 | -3.57% | ₹22,772.12 | 100.43 | +128.70% | |
| ₹1,622.10 | +0.23% | ₹22,124.32 | 28.16 | -9.34% | |
| ₹487.80 | +2.93% | ₹17,687.36 | 32.37 | +29.05% | |
| ₹5,998.00 | +0.33% | ₹17,659.16 | 21.69 | -0.56% | |
| ₹5,422.50 | -1.44% | ₹16,625.37 | 38.52 | +16.41% | |
| ₹3,421.20 | +1.27% | ₹14,808.88 | 22.73 | -25.49% | |
| ₹1,165.00 | +1.16% | ₹13,263.51 | 58.35 | -8.09% |
An investment of ₹10,000 made 5 years ago in Camlin Fine Sciences is now worth
₹ 4,825.00
resulting in a loss of
₹ 5,175.00 (51.75%)
Note: Past profits do not guarantee future returns.
